FDA Inspection 1091471 — University of Pittsburg Medical Center, Hillman Cancer Center
The FDA completed an inspection of University of Pittsburg Medical Center, Hillman Cancer Center on May 13, 2019 in Carlisle, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 13, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Carlisle, PA (United States)